Dr. Milan Radovich, PhD, is an Associate Professor at the Indiana University School of Medicine (IUSM) and Vice President for Oncology Genomics at Indiana University Health (IUH). He is also co-director of the IU Health Precision Genomics Program, a clinical program dedicated to the integration of cutting-edge genomics for the care of metastatic cancer patients.
As an NCI-funded investigator, his research expertise focuses on the use of genomics in translational oncology. In particular, his research concentrates on the use of genomics in clinical studies, genomically-informed drug combinations, circulating biomarkers of cancer detection, and creating novel bioinformatic pipelines for cancer genome analyses. His laboratory has long standing-expertise in the research of triple-negative breast cancer, thymic malignancies, and cancer precision medicine.
As IUH Vice President for Oncology Genomics and co-director of the IU Health Precision Genomics Program, he co-leads a clinical service line that uses genomics to guide therapy for cancer patients. This program has sequenced over 5000 patients to date. With five clinics across the state of Indiana, the program provides access to cutting-edge genomic-based cancer care for patients.
Dr. Radovich is passionate about providing the best care to patients through precision medicine. He actively engages with patient advocacy, philanthropic groups, and mentoring to bring genomics research to patients. He is also actively involved in national precision medicine research as the ORIEN network scientific committee co-chair, a member of the Big Ten Cancer Research Consortium Basket Trials Working Group, and also served in the NCI Cancer Genome Atlas (TCGA). When he is not in the cancer center or in the lab, he enjoys spending time with his family. As a native Chicagoan and Purdue graduate, he also enjoys cheering on the Bears and Boilermakers.